McDonald, M. M., Reagan, M. R., & Seckinger, A. (2017). Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma. Blood, 129(26), . https://doi.org/10.1182/blood-2017-03-773341
Chicago Style (17th ed.) CitationMcDonald, Michelle M., Michaela R. Reagan, and Anja Seckinger. "Inhibiting the Osteocyte-specific Protein Sclerostin Increases Bone Mass and Fracture Resistance in Multiple Myeloma." Blood 129, no. 26 (2017). https://doi.org/10.1182/blood-2017-03-773341.
MLA (9th ed.) CitationMcDonald, Michelle M., et al. "Inhibiting the Osteocyte-specific Protein Sclerostin Increases Bone Mass and Fracture Resistance in Multiple Myeloma." Blood, vol. 129, no. 26, 2017, https://doi.org/10.1182/blood-2017-03-773341.
Warning: These citations may not always be 100% accurate.